Patent · US Active

Delivery system for nucleic acids

US7803399B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 3, 2006
Grant dateSep 28, 2010
Priority date—
Expiry dateApr 7, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

αvβ3 Integrin receptor targeting liposomes comprise a cationic amphiphile such as a cationic lipid, a neutral lipid, and a targeting lipid. The targeting lipid includes a non-peptidic αvβ3 integrin antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.